SAMH
Shanda Asset Management Holdings Portfolio holdings
AUM
$1.84B
This Quarter Return
+15.28%
1 Year Return
+17.66%
3 Year Return
+105.04%
5 Year Return
+163.25%
10 Year Return
+23.03%
AUM
$720M
AUM Growth
+$720M
(-5.4%)
Cap. Flow
-$129M
Cap. Flow
% of AUM
-17.84%
Top 10 Holdings %
Top 10 Hldgs %
83.13%
Holding
93
New
5
Increased
9
Reduced
7
Closed
57
Top Buys
| 1 |
Zoom
ZM
|
$47M |
| 2 |
Amazon
AMZN
|
$31.5M |
| 3 |
Meta Platforms (Facebook)
META
|
$26.2M |
| 4 |
TSMC
TSM
|
$24.3M |
| 5 |
Walmart
WMT
|
$17.2M |
Top Sells
| 1 |
Alphabet (Google) Class A
GOOGL
|
$85.1M |
| 2 |
JPMorgan Chase
JPM
|
$28.2M |
| 3 |
Walt Disney
DIS
|
$22.3M |
| 4 |
Visa
V
|
$20M |
| 5 |
Blackrock
BLK
|
$19.7M |
Sector Composition
| 1 | Technology | 33.19% |
| 2 | Consumer Discretionary | 19.86% |
| 3 | Healthcare | 19.58% |
| 4 | Financials | 14.17% |
| 5 | Communication Services | 7.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Essex Property Trust
ESS
$16.8B
| – | – |
-8,400
| Closed | -$1.93M |
|
77
Equity Residential
EQR
$24.7B
| – | – |
-23,750
| Closed | -$1.4M |
|
|
78
Walt Disney
DIS
$211B
| – | – |
-200,000
| Closed | -$22.3M |
|
79
Boeing
BA
$176B
| – | – |
0
| – | – |
|
80
AvalonBay Communities
AVB
$27.2B
| – | – |
-50,000
| Closed | -$7.73M |
|
81
Atara Biotherapeutics
ATRA
$88.7M
| – | – |
-37,425
| Closed | -$545K |
|
82
ASML
ASML
$290B
| – | – |
-30,000
| Closed | -$11M |
|
83
Ardelyx
ARDX
$1.57B
| – | – |
-37,952
| Closed | -$263K |
|
84
Aprea Therapeutics
APRE
$8.91M
| – | – |
-11,863
| Closed | -$460K |
|
85
AnaptysBio
ANAB
$630M
| – | – |
-20,039
| Closed | -$448K |
|
86
Aldeyra Therapeutics
ALDX
$350M
| – | – |
-31,000
| Closed | -$129K |
|
87
AbbVie
ABBV
$374B
| – | – |
-20,867
| Closed | -$2.05M |
|
|
BCLI
88
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| – | – |
-23,000
| Closed | -$258K |
|
89
Chewy
CHWY
$16.8B
| – | – |
-89,800
| Closed | -$4.01M |
|
90
Camden Property Trust
CPT
$11.7B
| – | – |
-12,700
| Closed | -$1.16M |
|
91
Corbus Pharmaceuticals
CRBP
$121M
| – | – |
-63,371
| Closed | -$532K |
|
92
CervoMed
CRVO
$93M
| – | – |
-61,000
| Closed | -$59K |
|
93
CEL-SCI Corp
CVM
$81.4M
| – | – |
-33,000
| Closed | -$492K |
|